Lantheus Holdings, Inc. (LNTH)

NASDAQ: LNTH · IEX Real-Time Price · USD
62.82
+1.53 (2.50%)
At close: Jun 24, 2022 4:00 PM
62.95
+0.13 (0.21%)
After-hours: Jun 24, 2022 5:38 PM EDT
2.50%
Market Cap 4.31B
Revenue (ttm) 541.58M
Net Income (ttm) -37.33M
Shares Out 68.63M
EPS (ttm) -0.56
PE Ratio n/a
Forward PE 31.45
Dividend n/a
Ex-Dividend Date n/a
Volume 2,139,749
Open 62.33
Previous Close 61.29
Day's Range 61.01 - 64.32
52-Week Range 22.20 - 73.78
Beta 0.75
Analysts Buy
Price Target 93.64 (+49.1%)
Earnings Date Jul 27, 2022

About LNTH

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-label... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Jun 25, 2015
CEO Mary Heino
Employees 612
Stock Exchange NASDAQ
Ticker Symbol LNTH
Full Company Profile

Financial Performance

In 2021, LNTH's revenue was $425.21 million, an increase of 25.28% compared to the previous year's $339.41 million. Losses were -$71.28 million, 429.1% more than in 2020.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for LNTH stock is "Buy." The 12-month stock price forecast is 93.64, which is an increase of 49.06% from the latest price.

Price Target
$93.64
(49.06% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Best Growth Stocks to Buy for June 24th

MPC, LNTH, and LUV made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 24, 2022.

Other symbols: LUVMPC

Best Growth Stocks to Buy for June 20th

MPC, CLR, and LNTH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 20, 2022.

Other symbols: CLRMPC

Lantheus Announces Promotion of Paul Blanchfield to Chief Operating Officer

Dottie Barr Promoted to Senior Vice President, Manufacturing and Technical Operations Dottie Barr Promoted to Senior Vice President, Manufacturing and Technical Operations

Lantheus Holdings (LNTH) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After losing some value lately, a hammer chart pattern has been formed for Lantheus Holdings (LNTH), indicating that the stock has found support. This, combined with an upward trend in earnings estimate...

Lantheus Highlights Preliminary Study Results Demonstrating Potential of NM-01, a Novel Technetium-99m SPECT/CT Imagi...

Study Results Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting Study Results Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Me...

Lantheus' PYLARIFY AI™ Platform Demonstrates Higher Efficiency and Consistency While Maintaining Accuracy for Assessm...

Study Results Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in Vancouver Study Results Presented at the Society of Nuclear Medicine and Molecular Imaging (SNM...

How Much Upside is Left in Lantheus Holdings (LNTH)? Wall Street Analysts Think 27%

The average of price targets set by Wall Street analysts indicates a potential upside of 26.6% in Lantheus Holdings (LNTH). While the effectiveness of this highly sought-after metric is questionable, th...

What Makes Lantheus Holdings (LNTH) a Good Fit for "Trend Investing"

Lantheus Holdings (LNTH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it thro...

Lantheus to Present at the Jefferies Healthcare Conference

NORTH BILLERICA, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diag...

7 Hot Stocks to Buy During the Next Market Crash

These aren't likely the stocks you think about when you think about hot stocks, but that's what makes them so special. The post 7 Hot Stocks to Buy During the Next Market Crash appeared first on Investo...

Other symbols: BLDRCFCVEICLSQMWIRE

Lantheus Announces Presentations Featuring PYLARIFY® (Piflufolastat F18), PYLARIFY AI™ and NM-01 (PD-L1 Imaging) at t...

NORTH BILLERICA, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagn...

Wall Street Analysts Predict a 44% Upside in Lantheus Holdings (LNTH): Here's What You Should Know

The consensus price target hints at a 44.2% upside potential for Lantheus Holdings (LNTH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings e...

Lantheus Hosts Inaugural Investor Day

Lantheus Outlines Sustainable and Profitable Growth Strategy; Introduces Long-Term Financial Targets Lantheus Outlines Sustainable and Profitable Growth Strategy; Introduces Long-Term Financial Targets

Lantheus Holdings (LNTH) Just Overtook the 20-Day Moving Average

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

Lantheus Holdings (LNTH) Is a Great Choice for "Trend" Investors, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Lantheus Holdings (LNTH) could be a great choice. It is one of the several stocks that passed through our "Recent...

Lantheus Presents Results from a PYLARIFY AI™ Study at the American Urological Association (AUA) Annual Meeting

Retrospective analysis demonstrates reliability of PSMA scan indices as response-imaging biomarker to androgen therapy in prostate cancer Retrospective analysis demonstrates reliability of PSMA scan ind...

New Analysts Initiate Coverage: Top 5 Stocks on Radar

Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Bancolombia (CIB), Lantheus (LNTH), A-Mark (AMRK), Patrick (PATK) and LCI (LCII).

Other symbols: AMRKCIBLCIIPATK

Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD-L1 Expression in Non-Small Ce...

NM-01 is a novel technetium-99m SPECT imaging agent currently being developed for the assessment of PD-L1 expression in cancer cells NM-01 is a novel technetium-99m SPECT imaging agent currently being d...

Lantheus Announces Updates to the NCCN Guidelines for PSMA PET Imaging for Prostate Cancer

PYLARIFY® (piflufolastat F18) injection was the first commercially available PSMA-targeted PET imaging agent for prostate cancer PYLARIFY® (piflufolastat F18) injection was the first commercially availa...

Lantheus to Present at the UBS Global Healthcare Conference

NORTH BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagn...

Is Lantheus (LNTH) Outperforming Other Medical Stocks This Year?

Here is how Lantheus Holdings (LNTH) and Vertex Pharmaceuticals (VRTX) have performed compared to their sector so far this year.

Best Momentum Stocks to Buy for May 6th

LNTH, TGLS, and APA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 6, 2022.

Other symbols: APATGLS

Why Lantheus Holdings' Shares Are Up 16.4% Friday

A better-than-expected earnings report has investors buying.

Lantheus Holdings (LNTH) Beats Q1 Earnings and Revenue Estimates

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 110.87% and 26.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Lantheus Holdings, Inc. Reports First Quarter 2022 Financial Results

NORTH BILLERICA, Mass., April 29, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging diagnost...